King International Investment (HKSE:00928) Operating Margin %: 4.83% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is King International Investment Operating Margin %?

King International Investment HKSE:00928 -4.85% Operating Margin % is 4.83% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, King International Investment ranks better than 64.04% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. King International Investment's Operating Income for the six months ended in Mar. 2026 was HK$3.3 Mil. King International Investment's Revenue for the six months ended in Mar. 2026 was HK$69.3 Mil. Therefore, King International Investment's Operating Margin % for the quarter that ended in Mar. 2026 was 4.83%.

The historical rank and industry rank for King International Investment's Operating Margin % or its related term are showing as below:

HKSE:00928' s Operating Margin % Range Over the Past 10 Years
Min: -199.9   Med: -31.71   Max: 7.55
Current: 6.33


HKSE:00928's Operating Margin % is ranked better than
64.04% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.29 vs HKSE:00928: 6.33

King International Investment's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

King International Investment's Operating Income for the six months ended in Mar. 2026 was HK$3.3 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was HK$9.1 Mil.


King International Investment  (HKSE:00928) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


King International Investment Operating Margin % Related Terms


King International Investment Operating Margin % Historical Data

* Premium members only.

The historical data trend for King International Investment's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

King International Investment Operating Margin % Chart

King International Investment Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.09 -14.53 7.55 -32.28 6.33

King International Investment Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.89 -3.97 -326.40 7.73 4.83

HKSE:00928 vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, King International Investment's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's Operating Margin % distribution charts can be found below:

* The bar in red indicates where King International Investment's Operating Margin % falls into.



King International Investment Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

King International Investment's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=9.061 / 143.228
=6.33 %

King International Investment's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=3.348 / 69.309
=4.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 4.83% mean?
King International Investment (HKSE:00928) has a Operating Margin % of 4.83% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on King International Investment and its competitors. According to the industry distribution chart, King International Investment ranks #73 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 36%.
Is King International Investment's Operating Margin % too high?
King International Investment's current Operating Margin % is 4.83%. Based on the distribution chart, King International Investment ranks #73 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does King International Investment's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, King International Investment ranks #73 out of 203 companies for Operating Margin %. This puts King International Investment in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on King International Investment and its competitors. King International Investment's current Operating Margin % is 4.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is King International Investment stock overvalued right now?
Based on GuruFocus' analysis, King International Investment (HKSE:00928) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.04, compared to a current price of HK$0.10 — trading 145% above its estimated fair value. The current Operating Margin % is 4.83%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For King International Investment (HKSE:00928), the current Operating Margin % is 4.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

King International Investment Business Description

Address 15 Queen’s Road Central, 1101, 11th Floor, Gloucester Tower, The Landmark, Hong Kong, HKG
King International Investment Ltd is an investment holding company. Its operating segments include healthcare products and services, money lending, and liquor sales, with the majority of revenue generated from the liquor sales segment. The group provides genetic testing and develops domestic healthcare equipment services. Leveraging its strengths, the group integrates health data analysis software with healthcare equipment to offer new healthcare services and products. Geographically, it derives the majority of its revenue from the PRC.